Fulgent Genetics (FLGT) Analyst Estimates Annual - Discounting Cash Flows
Fulgent Genetics, Inc.
FLGT (NASDAQ)

* (except for per share items) of USD
Period Ending: 2027
12-31
2026
12-31
2025
12-31
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
Number of Analysts 2 3 2 2 2 1 1 1 1 1 1 1
Estimated Revenue
Low 370 337 299 280 278 596 913 319 31.9 21.1 19.1 18.0
Average 370 341 310 282 278 611 933 326 32.6 21.5 19.6 18.4
High 370 346 322 284 278 629 958 335 33.5 22.1 20.1 18.9
Estimated EBITDA
Low 96.7 87.9 78.1 73.0 72.7 378 502 96.7 9.68 -3.26 -10.0 5.47
Average 96.7 89.1 81.0 73.6 72.7 473 628 98.9 9.90 -2.71 -7.96 5.59
High 96.7 90.2 84.0 74.2 72.7 567 753 102 10.2 -2.17 -5.88 5.74
Estimated EBIT
Low 84.1 76.4 67.9 63.5 63.2 359 488 79.7 7.97 -5.04 -13.7 4.50
Average 84.1 77.4 70.5 64.0 63.2 449 610 81.4 8.15 -4.20 -11.3 4.60
High 84.1 78.5 73.0 64.6 63.2 539 732 83.6 8.37 -3.36 -8.95 4.73
Estimated Net Income
Low -15.1 -20.3 -99.1 8.94 -201 269 368 181 3.30 -6.01 -10.4 9.48
Average -14.7 -19.2 -59.9 9.69 -168 337 461 186 3.40 -5.00 -8.53 9.75
High -14.4 -18.1 59.5 10.4 -134 404 553 193 3.51 -4.00 -6.71 10.1
Estimated SGA Expenses
Low 94.8 86.2 76.6 71.5 98.3 84.8 52.8 77.8 7.79 7.40 4.67 4.40
Average 94.8 87.3 79.4 72.2 123 106 66.0 79.5 7.96 9.25 4.77 4.49
High 94.8 88.5 82.3 72.8 147 127 79.2 81.7 8.18 11.1 4.90 4.62
Estimated EPS
Low -0.498 -0.670 -3.278 0.296 -1.045 5.433 15.24 6.081 0.111 -0.098 0.003 0.318
Average -0.487 -0.630 -0.656 0.325 -0.976 5.612 15.68 6.258 0.114 -0.095 0.003 0.327
High -0.477 -0.600 1.967 0.345 -0.907 5.830 16.23 6.477 0.118 -0.092 0.003 0.339
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us